Asst. Prof. Dr. Ratthaphol  Kraiklang

Email: This email address is being protected from spambots. You need JavaScript enabled to view it. and This email address is being protected from spambots. You need JavaScript enabled to view it.

Research areas: diabetes mellitus, phytochemical, plant extracts, and chronic kidney disease

Teaching areas: Nutrition

Education:

1997-2000: B.Sc. (Sanitary Science, Second Class Honor), Faculty of Public Health, Khon Kaen University, Khon Kaen, Thailand.

2003-2007: M.Sc. (Medical Biochemistry), Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. Thesis title is “Development of Cholangiocarcinoma DNA Array”.

2007-2013: Ph.D. (Medical Biochemistry), Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. Thesis title is “Identification of The Molecular Signature of Cholangiocarcinoma Using Real-time PCR”.

Selected publications (Scopus/ISI):

1. Laoraksawong P, Sanpool O, Rodpai R, Thanchomnang T, Kanarkard W, Maleewong W, Kraiklang R, Intapan PM. Impact of the health education and preventive equipment package (HEPEP) on prevention of Strongyloides stercoralis infection among rural communities in Northeast Thailand: a cluster randomized controlled trial. BMC Public Health. 2018 Oct 19; 18(1): 1184.

2. Laoraksawong P, Sanpool O, Rodpai R, Thanchomnang T, Kanarkard W, Maleewong W, Kraiklang R, Intapan PM. Current high prevalences of Strongyloides stercoralis and Opisthorchis viverrini infections in rural communities in northeast Thailand and associated risk factors. BMC Public Health. 2018 Jul 31; 18(1): 940.

3. Prasongdee TK, Laoraksawong P, Kanarkard W, Kraiklang R, Sathapornworachai K, Naonongwai S, Laummaunwai P, Sanpool O, Intapan PM, Maleewong W. An eleven-year retrospective hospital-based study of epidemiological data regarding human strongyloidiasis in northeast Thailand. BMC Infect Dis. 2017 Sep 18; 17(1): 627.

4. Thammakun T, Laohasiriwong W, Kraiklang R, Saengprajak N. Association of +62 G>A Polymorphism in the Resistin Gene with Type 2 Diabetes Mellitus among Thais: Case-Control Study. J Clin Diagn Res. 2017 Feb; 11(2): BC15-BC20.

5. Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity. Uthaisar K, Vaeteewoottacharn K, Seubwai W, Talabnin C, Sawanyawisuth K, Obchoei S, Kraiklang R, Okada S, Wongkham S. Oncol Rep. 2016 Sep;36(3):1435-46.

6. Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells. Seubwai W, Vaeteewoottacharn K, Kraiklang R, Umezawa K, Okada S, Wongkham S. Oncol Res. 2016;23(1):21-8.

7. Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma. Vaeteewoottacharn K, Kariya R, Dana P, Fujikawa S, Matsuda K, Ohkuma K, Kudo E, Kraiklang R, Wongkham C, Wongkham S, Okada S. Tumour Biol. 2016 Jan 13.

8. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma. Sawanyawisuth K, Tantapotinan N, Wongkham C, Riggins GJ, Kraiklang R, Wongkham S, Puapairoj A. Ann Hepatol. 2016 Jan-Feb;15(1):71-81.

9. Kraiklang R, Pairojkul C, Khuntikeo N, Imtawil K, Wongkham S, Wongkham C. A novel predictive equation for potential diagnosis of cholangiocarcinoma. PLoS One. 2014; 9(2): e89337.

10. Sribenja S, Sawanyawisuth K, Kraiklang R, Wongkham C, Vaeteewoottacharn K, Obchoei S, et al. Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma. BMC Cancer. 2013; 13: 430.

.................................................................................................................................................................................